These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8701403)

  • 1. Feasibility of using recombinant factor VIIa in continuous infusion.
    Schulman S; Bech Jensen M; Varon D; Keller N; Gitel S; Horoszowski H; Heim M; Martinowitz U
    Thromb Haemost; 1996 Mar; 75(3):432-6. PubMed ID: 8701403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences with continuous infusion of recombinant activated factor VII.
    Schulman S; d'Oiron R; Martinowitz U; Pasi J; Briquel ME; Mauser-Bunschoten E; Morfini M; Ritchie B; Goudemand J; Lloyd J; McPherson J; Négrier C; Peerlinck K; Petrini P; Tusell J
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S97-101. PubMed ID: 9819037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of recombinant activated factor VII: stability in infusion pump systems.
    Bonde C; Jensen MB
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S103-5. PubMed ID: 9819038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous infusion of recombinant activated factor VII during and after elbow arthroplasty in a hemophilia A patient with inhibitors].
    Nakamura M; Terashima K; Takashima Y; Amano K; Horikoshi Y; Mimaya J
    Rinsho Ketsueki; 2002 Mar; 43(3):183-8. PubMed ID: 11979750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.
    Schulman S; Varon D; Keller N; Gitel S; Martinowitz U
    Thromb Haemost; 1994 Sep; 72(3):403-7. PubMed ID: 7855792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.
    Smith MP; Ludlam CA; Collins PW; Hay CR; Wilde JT; Grigeri A; Melsen T; Savidge GF
    Thromb Haemost; 2001 Oct; 86(4):949-53. PubMed ID: 11686351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.
    Schulman S; Tjønnfjord GE; Wallensten R; Martinowitz U; Kenet G
    Thromb Haemost; 2005 Dec; 94(6):1177-80. PubMed ID: 16411390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy.
    Petrini P; Klementz G
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S143-6. PubMed ID: 9819046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitor.
    Stewart AJ; Hanley JP; Ludlam CA
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S93-5. PubMed ID: 9819036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with activated factor VII: focus on safety aspects.
    Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S115-8. PubMed ID: 9819041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts].
    Auerswald G; Muntean W; Kemkes-Matthes B; Klamroth R; Krause M; Kurnik K; Oldenburg J; Pabinger-Fasching I; Schramm W; Zimmermann R; Zotz RB
    Hamostaseologie; 2009 May; 29(2):197-203. PubMed ID: 19404511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor.
    Montoro JB; Altisent C; Pico M; Cabañas MJ; Vila M; Puig LL
    Haemophilia; 1998 Sep; 4(5):762-5. PubMed ID: 9873885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated factor VII as a universal haemostatic agent.
    Hedner U
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
    Ingerslev J; Holm M; Christiansen K; Knudsen L; Négrier C
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro stability of two formulations of recombinant activated factor VIIa reconstituted in inappropriate solvents or at inappropriate volumes.
    Petersson B; Schönwandt AB; Thornstfeldt P; Nedergaard H; Jensen MB; Thornstergaard PB; Norsell T; Bjerre J
    Clin Ther; 2008 May; 30(5):917-23. PubMed ID: 18555938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative use of rFVIIa by continuous infusion in a haemophilic boy.
    Lorenzo JI; Montoro JM; Aznar JA
    Haemophilia; 1999 Mar; 5(2):135-8. PubMed ID: 10215964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.